Mcilroy, George DMitchell, Sharon EHan, WeipingDelibegović, MirelaRochford, Justin J2020-01-232020-01-232020-01-17Mcilroy, G D, Mitchell, S E, Han, W, Delibegović, M & Rochford, J J 2020, 'Ablation of Bscl2/Seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy', Disease Models & Mechanisms, vol. 13, no. 1, dmm042655. https://doi.org/10.1242/dmm.0426551754-8403ORCID: /0000-0002-5020-4939/work/79062189ORCID: /0000-0003-4230-4355/work/102133116ORCID: /0000-0001-6193-3152/work/160847571https://hdl.handle.net/2164/13584Funding Work was supported by the Medical Research Council (GDM/JJR; MR/L002620/1, MC/PC/15077), the Biotechnology and Biological Sciences Research Council (JJR; BB/K017772/1), Diabetes UK (GDM/JJR; 18/0005884), the British Heart Foundation (MD;PG/14/43/30889) and the Wellcome Trust and the University of Aberdeen ISSF Fund (GDM; ISSF Fellowship Support Fund).102410511engSDG 3 - Good Health and Well-beingLipodystrophyBSCL2CGLHepatocyteAAVCRISPRBSCL2CGLINSULIN SENSITIVITYSEIPINLIPOLYSISRESISTANCEMICEKNOCKOUTR MedicineImmunology and Microbiology (miscellaneous)General Biochemistry,Genetics and Molecular BiologyNeuroscience (miscellaneous)Medicine (miscellaneous)Medical Research Council (MRC)MR/L002620/1MC/PC/15077Biotechnology and Biological Sciences Research Council (BBSRC)BB/K017772/1British Heart FoundationMD;PG/14/43/30889Wellcome TrustISSF Fellowship Support FundRJournal article10.1242/dmm.042655http://www.scopus.com/inward/record.url?scp=85078504837&partnerID=8YFLogxK131